Forecast & Rating3 analysts currently cover Inhibrx Biosciences, of which 2 give a positive rating. The average price target is $277.50, about 236.6% upside from the current price of $82.45. Coverage is limited, so the data is for reference only. Data as of Jun 3, 2026; this does not constitute investment advice.
Jun 2, 2026
Price forecast
$277.50236.57%
Forecast & RatingBuy
3analysts
Strong buy66.67%
Buy0.00%
Hold33.33%
Sell0.00%
Strong sell0.00%
Strong buy
2
Buy
0
Hold
1
Sell
0
Strong sell
0
Target price forecast
Forecast baselineMay 31, 2026
Forecast met69.1%
Stock price$99.29
Average forecast price$277.5
Highest forecast price$325
Lowest forecast price$230
Average forecast price
$277.5
Highest forecast price
$325
Lowest forecast price
$230
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.